Literature DB >> 22533919

Clostridium difficile carbohydrates: glucan in spores, PSII common antigen in cells, immunogenicity of PSII in swine and synthesis of a dual C. difficile-ETEC conjugate vaccine.

Lisa Bertolo1, Alexander G Boncheff, Zuchao Ma, Yu-Han Chen, Terra Wakeford, Robert M Friendship, Joyce Rosseau, J Scott Weese, Michele Chu, Michael Mallozzi, Gayatri Vedantam, Mario A Monteiro.   

Abstract

Clostridium difficile is responsible for severe diarrhea in humans that may cause death. Spores are the infectious form of C. difficile, which germinate into toxin-producing vegetative cells in response to bile acids. Recently, we discovered that C. difficile cells possess three complex polysaccharides (PSs), named PSI, PSII, and PSIII, in which PSI was only associated with a hypervirulent ribotype 027 strain, PSII was hypothesized to be a common antigen, and PSIII was a water-insoluble polymer. Here, we show that (i) C. difficile spores contain, at least in part, a D-glucan, (ii) PSI is not a ribotype 027-unique antigen, (iii) common antigen PSII may in part be present as a low molecular weight lipoteichoic acid, (iv) selective hydrolysis of PSII yields single PSII repeat units, (v) the glycosyl diester-phosphate linkage affords high flexibility to PSII, and (vi) that PSII is immunogenic in sows. Also, with the intent of creating a dual anti-diarrheal vaccine against C. difficile and enterotoxin Escherichia coli (ETEC) infections in humans, we describe the conjugation of PSII to the ETEC-associated LTB enterotoxin.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533919     DOI: 10.1016/j.carres.2012.03.032

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  16 in total

Review 1.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 2.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

3.  Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats.

Authors:  Brandi Limbago; Angela D Thompson; Sharon A Greene; Duncan MacCannell; Charles E MacGowan; Beverly Jolbitado; Henrietta D Hardin; Stephanie R Estes; J Scott Weese; J Glenn Songer; L Hannah Gould
Journal:  Food Microbiol       Date:  2012-08-21       Impact factor: 5.516

Review 4.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

5.  α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge.

Authors:  Gillian A Lang; Binu Shrestha; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

6.  Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.

Authors:  Maria R Romano; Rosanna Leuzzi; Emilia Cappelletti; Marta Tontini; Alberto Nilo; Daniela Proietti; Francesco Berti; Paolo Costantino; Roberto Adamo; Maria Scarselli
Journal:  Toxins (Basel)       Date:  2014-04-22       Impact factor: 4.546

7.  A Clostridium difficile Cell Wall Glycopolymer Locus Influences Bacterial Shape, Polysaccharide Production and Virulence.

Authors:  Michele Chu; Michael J G Mallozzi; Bryan P Roxas; Lisa Bertolo; Mario A Monteiro; Al Agellon; V K Viswanathan; Gayatri Vedantam
Journal:  PLoS Pathog       Date:  2016-10-14       Impact factor: 6.823

Review 8.  A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.

Authors:  Csaba Fehér; Alex Soriano; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-12-01

9.  Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII.

Authors:  Stephanie E Willing; Thomas Candela; Helen Alexandra Shaw; Zoe Seager; Stéphane Mesnage; Robert P Fagan; Neil F Fairweather
Journal:  Mol Microbiol       Date:  2015-03-06       Impact factor: 3.501

10.  Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.

Authors:  Felix Broecker; Jonas Hanske; Christopher E Martin; Ju Yuel Baek; Annette Wahlbrink; Felix Wojcik; Laura Hartmann; Christoph Rademacher; Chakkumkal Anish; Peter H Seeberger
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.